Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug

Taylor, A.I.P., Xu, Y., Wilkinson, M. et al. (7 more authors) (2025) Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug. Journal of the American Chemical Society. ISSN 0002-7863

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0 .

Dates:
  • Published (online): 21 February 2025
  • Accepted: 10 February 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds) > Structural Molecular Biology (Leeds)
Funding Information:
Funder
Grant number
Royal Society
RSRP\R1\211057
Depositing User: Symplectic Publications
Date Deposited: 14 Feb 2025 10:38
Last Modified: 05 Mar 2025 17:29
Published Version: https://pubs.acs.org/doi/10.1021/jacs.4c16743
Status: Published online
Publisher: American Chemical Society
Identification Number: 10.1021/jacs.4c16743
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics